Mr. Speaker, today I would like to congratulate the three recipients of the Prix Galien Canada research award, who were honoured last night in Montreal.
They are, first, Drs. Julia Levy and David Dolphin of British Columbia, for Visydune, a drug used to fight blindness and distributed in 52 countries, and Dr. Anthony J. Paulson, for his drug, Gleevec, used to treat leukemia.
The Galien Canada award is a prestigious honour in the field of pharmaceutical research and innovation. Galien, also known as Galen and Claudius Galenus, is considered the father of experimental physiology and the precursor of modern pharmacology.
The Government of Canada's $7.4 billion contribution to research and development was also celebrated by the industry, particularly for the creation of the institutes for health research, the Canadian Foundation for Innovation, Genome Canada and the research chairs.